Calibre What Science Can Do
This website contains promotional content about AstraZeneca Medications. This website is intended for healthcare professionals involved in the Acute Coronary Syndrome care pathway, such as hospital specialists from cardiology and cardiology-related departments, including A&E and elderly care, as well as GPs with a specific interest in cardiology, nurses, pharmacists and payers with budget responsibilities in cardiology.
Recognition of the ongoing ischaemic risk our patients face
Prof Johanne Silvain
Dr Johanne Silvain is a Professor of Medicine at the University of Pierre and Marie Curie in Paris, France. He is an interventional cardiologist, with expertise in coronary angioplasty and CTO and is the Director of the Coronary Intensive Care Unit. He qualified at the University of Medicine of Paris (UPMC) and has authored over 100 publications in established and respected journals. Dr Silvain’s research interests lie in the area of thrombosis (thrombotic composition) to antithrombotic (anticoagulant and antiplatelet agents) and its consequences on bleeding and transfusion.
Individualised patient approaches for DAPT; duration to 12 months
Dr Christopher Granger
Dr Christopher Granger
Dr. Granger, MD is a Professor of Medicine in the Division of Cardiology and a member of the Duke Clinical Research Institute, Duke University School of Medicine in North Carolina, USA. Dr. Granger is a Fellow of the American College of Cardiology, the American Heart Association and of the European Society of Cardiology. His primary research interests are in the conduct and methodology of large randomized trials in heart disease. He is Associate Editor of the American Heart Journal and serves on the editorial board of the Journal of American College of Cardiology.
Individualised patient approaches for DAPT; duration beyond 12 months
Dr Dominick Angiolillo
Dr. Angiolillo joined the University of Florida College of Medicine – Jacksonville in 2004. Currently, Dr. Angiolillo is a Professor of Medicine with tenure status. He is also the Director of Cardiovascular Research, Program Director of the Interventional Cardiology Fellowship Program and a Staff Cardiologist and Interventional Cardiologist with the University of Florida Health System. Dr. Angiolillo is board certified by the American Board of Internal Medicine in internal medicine, cardiovascular disease and interventional cardiology.